Regard, an AI-based clinical insights platform that empowers clinicians to unlock the full potential of patient data, announced the closing of a $61 million Series B financing round, led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures, and existing investors TenOneTen Ventures, Calibrate Ventures, and Techstars.
This funding will enable the company to accelerate product development with its core clinical insights platform, invest in fundamental research in large language models (LLMs), and expand beyond inpatient facilities.
An infusion of new technologies has generated more healthcare data than ever, but much of it remains untapped for clinical care. With an average of 50,000 data points per patient, the gap between the vast amount of data available and clinically actionable insights generated from it is significant.
Regard bridges the insights gap by analyzing all available data and recommending diagnoses, enabling clinicians to deliver better care. After the clinician reviews and approves recommendations, Regard ensures complete and accurate documentation in a standardized format, a critical step to ensure clinical quality and enhance hospital revenue.
Since launching in 2021, Regard’s technology has surfaced more than three million diagnoses for care teams and generated over $50 million in incremental revenue for enterprise health system partners, including Banner Health and Sentara. The company also recently announced a partnership with WakeMed Health & Hospitals, a leading health system in Raleigh, North Carolina.
KEY QUOTES:
“Regard is positioned to revolutionize how we think about clinical decision-making support for doctors. The team at Regard has built a platform that is driving value for patients, physicians and health systems alike by improving outcomes, increasing efficiency, reducing burnout, and increasing revenue. Eli and Nate have been thoughtful about product development and we are thrilled to be a part of this next chapter where they look to deliver this value at scale.”
– Nancy Brown, General Partner at Oak HC/FT
“Cedars-Sinai has been working alongside Regard from the early days of the business because we saw a real need to empower physicians with the data that can provide critical analysis and insights to assist in diagnosis and treatment. And, even more importantly, we believe it will improve patient care as well as the patient experience.”
– Maureen Burgess, Partner at Cedars-Sinai Health Ventures
“Imagine a doctor having all the EHR information they need about a patient, right in front of them, in just seconds. Regard is augmenting patient care by analyzing overwhelming mountains of clinical data and providing clinicians with potential diagnoses and treatment recommendations, impacting the quality and safety of care in real-time. That’s a game-changer – not just for doctors, but for the people whose lives are in their hands.”
– Eli Ben-Joseph, CEO at Regard
